Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
341.40    3.80 (1.13%)
Bid:
341.20
Ask:
341.60
Spread: 0.40 (0.117%)
Market Cap: £2.49b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Statement re transaction with ICAP

6 Dec 2016 13:40

RNS Number : 1057R
Tullett Prebon PLC
06 December 2016
 

For immediate release

 

6 December 2016

 

Tullett Prebon plc

 

Update on the acquisition of ICAP's global hybrid voice broking and information business

 

The Board of directors of Tullett Prebon plc ("Tullett Prebon") is pleased to note the publication today of a prospectus by NEX Group plc ("NEX") (the "NEX Prospectus") in relation to the admission of the ordinary shares of NEX to the premium listing segment of the Official List and to trading on the main market for listed securities of the London Stock Exchange. The NEX Prospectus has been prepared in connection with a scheme of arrangement pursuant to Part 26 of the Companies Act 2006 to introduce NEX as the new holding company of ICAP plc ("ICAP"). The Board of directors of Tullett Prebon expects the acquisition by Tullett Prebon of ICAP's global hybrid voice broking and information business, including ICAP's associated technology and broking platforms and certain of ICAP's joint ventures and associates (the "Transaction") to complete on 30 December 2016. Completion of the Transaction remains subject to the satisfaction or waiver of a number of conditions.

 

On completion of the Transaction, Tullett Prebon will issue new Tullett Prebon shares directly to NEX shareholders, such that NEX shareholders will hold, in aggregate, approximately 56 per cent. of the issued share capital of Tullett Prebon and existing Tullett Prebon shareholders will hold, in aggregate, approximately 44 per cent. of the issued share capital of Tullett Prebon (calculated on a fully diluted basis and immediately following such issuance). The new Tullett Prebon shares to be issued to NEX shareholders are expected to be admitted to the premium listing segment of the Official List maintained by the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities at 8:00 a.m. on 30 December 2016.

 

 

Ends

 

Enquiries:

Tullett Prebon

Alexandra Wick, Marketing & Communications Director

awick@tullettprebon.com

+44 (0) 20 7200 7579

 

Brunswick

Kim Fletcher, Eilis Murphy, Craig Breheny

tullettprebon@brunswickgroup.com

+44 (0) 20 7404 5959

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRAKADDNBDDQBK
Date   Source Headline
31st May 20233:52 pmRNSDirectorate Change
17th May 20235:05 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
13th Apr 202312:30 pmRNSHolding(s) in Company
5th Apr 20233:00 pmRNSDirector/PDMR Shareholding
4th Apr 202311:00 amRNSNotice of AGM and Committee Membership Changes
3rd Apr 20235:05 pmRNSDirector/PDMR Shareholding
29th Mar 20234:00 pmRNSHolding(s) in Company
23rd Mar 202311:00 amRNSDirector/PDMR Shareholding
22nd Mar 202311:00 amRNS2022 Annual Report and Accounts
14th Mar 20237:00 amRNSTP ICAP Group PLC - Final Results
8th Feb 20234:19 pmRNSChanges to Senior Independent Director
13th Dec 202210:00 amRNSHolding(s) in Company
6th Dec 20225:15 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSTrading Statement
27th Oct 20225:30 pmRNSHolding(s) in Company
25th Oct 20225:50 pmRNSHolding(s) in Company
13th Sep 20225:32 pmRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
28th Jul 20225:22 pmRNSResult of External Audit Tender
30th Jun 20225:44 pmRNSHolding(s) in Company
27th May 20223:30 pmRNSDirector/PDMR Shareholding
11th May 20226:01 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.